Citadel Advisors
POM

Citadel Advisors’s Pomdoctor Ltd POM Stock Holding History

Citadel Advisors’s Portfolio POM Stock Details POM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93.6K Buy
+20,256
New +$104K ﹤0.01% 12069

Other funds holding POM

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Citadel Advisors's POM Position: Q1 2026 in Review

Citadel Advisors opened a new position in Pomdoctor Ltd (POM) in Q1 2026: 20,256 shares worth $93.6K. The stake represents ﹤0.01% of the portfolio and ranks #12069 among its holdings.

10 funds tracked by Wall St. Rank hold POM as of Q1 2026.

  • Citadel Advisors held 20,256 shares of Pomdoctor Ltd worth $93.6K as of Q1 2026.
  • Pomdoctor Ltd was a new Citadel Advisors position in Q1 2026.
  • Pomdoctor Ltd made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12069 holding.
  • 10 funds tracked by Wall St. Rank held Pomdoctor Ltd as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.